Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known which combination chemotherapy regimen is more
effective for metastatic cancer of an unknown site of origin.
PURPOSE: Randomized phase III trial to compare the effectiveness of two combination
chemotherapy regimens in treating patients who have metastatic cancer of an unknown site of
origin.